Page 4 of 8
Who took part in this study?
Studies have a list of requirements for participants who can enter (inclusion criteria) and
those who cannot enter (exclusion criteria). For this study, the main inclusion and exclusion
criteria are listed below.
Men and women were included in the study if they:
• Were at least 18 years old.
• Had advanced PD-L1 positive NSCLC and have recovered from the unwanted
effects from previous cancer medicines.
• Were either fully active or unable to do hard physical activity but able to do
light house work or office work.
Men and women were excluded from the study if they had:
• Any other cancer.
• Were treated with medicines which are similar to niraparib or
pembrolizumab and dostarlimab.
• Any major surgery within three weeks before starting the study.
Overall, 53 participants received at least one dose of study medicine. Details are shown in
the figure below.